As of May 27
| +0.29 / +6.70%|
The 1 analysts offering 12-month price forecasts for Immunomedics Inc have a median target of 5.00, with a high estimate of 5.00 and a low estimate of 5.00. The median estimate represents a +8.23% increase from the last price of 4.62.
The current consensus among 2 polled investment analysts is to Buy stock in Immunomedics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.